In a Hollywood-style heist, thieves cut a hole in the roof of a warehouse, rappelled inside and scored one of the biggest hauls of its kind — not diamonds, gold bullion or Old World art, but about $75 million in antidepressants and ...
The Eli Lilly warehouse is seen here in Enfield, Conn., Tuesday, March 16, 2010. Authorities say tens of millions of dollars worth of prescription drugs have been stolen in a brazen, well-planned heist at a pharmaceutical company's regional warehouse in Connecticut. (AP ...
<div><p>Wall Street headed for a mixed open Thursday as investors eyed the release of key data on the troubled housing market and sifted through another stream of earnings reports.</p><p>A fresh reading on sales of existing homes will likely show sales resumed their ...
<div><p>Stocks skidded lower Thursday after a steeper-than-expected decline in sales of existing homes wiped away some of the market's optimism about upbeat earnings reports. The major indexes fell about 1 percent, including the Dow Jones industrial average, which fell more than 150 ...
<div><p>US drugmaker Eli Lilly pleaded guilty to violating US law in its marketing of anti-psychotic drug Zyprexa and will pay 1.42 billion dollars to settle criminal and civil allegations, officials said Thursday.</p><p>Eli Lilly said it had entered a misdemeanor plea for violation ...
<div id="subtitle">Amylin Pharmaceuticals says Carl Icahn would push to sell company to drugmaker Eli Lilly</div><div><p>Amylin Pharmaceuticals Inc. said Monday activist investor Carl Icahn plans to push for a sale of the company to drugmaker Eli Lilly if he can take control of ...
<div id="subtitle">Drugmaker Eli Lilly pleads guilty to misdemeanor in Zyprexa marketing case</div><div><p>The U.S. Attorney's Office for the Eastern District of Pennsylvania says drugmaker Eli Lilly & Co. formally pleaded guilty to a misdemeanor tied to the marketing of its top-seller, the anti-psychotic ...
<div><p><p>Thankfully for Genentech (NYSE: DNA), its own corner of the economy seems mostly recession-resistant. On Monday, the biotech reported another quarter of improving financials, despite ongoing tumult with the FDA and outside the biopharma sector.</p><p>Genentech reported yesterday that its first-quarter overall revenue ...
Focus on U.S. healthcare costs could be catalyst for biotech investment U.S. Hospital study a very important (and unrecognized) catalyst for BioMS Success Heading into 2009 we selected (through my microcap.com newsletter and on Stockhouse) only one biotech to follow for the ...
<div id="subtitle">General Motors, Eli Lilly, Dell, Amerigroup are among big market movers Wednesday</div><div><p>Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and Nasdaq Stock Market:</p><p>NYSE</p><p>General Motors Corp ...
